EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.

@article{Nogi2009EGFRAP,
  title={EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.},
  author={Hiroko Nogi and Tadashi Kobayashi and Masafumi Suzuki and Isao Tabei and Kazumi Kawase and Yasuo Toriumi and Hisaki Fukushima and K. Uchida},
  journal={Oncology reports},
  year={2009},
  volume={21 2},
  pages={413-7}
}
We retrospectively analyzed the expression of epidermal growth factor receptor (EGFR) as a prognostic marker to predict neoadjuvant chemotherapy response and survival among breast cancer subtypes. We used immunohistochemical profiles to subtype the patients. EGFR expression was determined using immunohistochemistry. All patients received an anthracycline-based regimen preoperatively. Ninety-three patients also received docetaxel. Of the 117 patients tested, 28 (24%) were triple-negative breast… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

, the so - called triple - negative phenotype

  • LA Carey, CM Perou, CA Livasy
  • 2007

Similar Papers

Loading similar papers…